Historically, women with T1a or bN0M0 early-stage breast cancer were considered to have a good prognosis; however, recent studies suggest that women with HER2-positive T1a or bN0M0 cancers may be at higher risk for recurrence8–11. This evidence concerns the gene ERBB2 and breast carcinoma.